Luke W Bonham1, Daniel S Evans2, Yongmei Liu3, Steven R Cummings2, Kristine Yaffe1,4,5,6, Jennifer S Yokoyama1. 1. 1 Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA. 2. 2 California Pacific Medical Center Research Institute, San Francisco, CA, USA. 3. 3 Department of Epidemiology and Prevention, Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. 4 Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. 5. 5 Department of Veterans Affairs, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA. 6. 6 Department of Psychiatry, University of California, San Francisco, CA, USA.
Abstract
BACKGROUND/RATIONALE: Experimental studies support the role of neurotransmitter genes in dementia risk, but human studies utilizing single variants in candidate genes have had limited success. METHODS: We used the gene-based testing program Versatile Gene-based Association Study to assess whether aggregate variation across 6 neurotransmitter pathways influences risk of cognitive decline in 8159 cognitively normal elderly (≥65 years old) adults from 3 community-based cohorts. RESULTS: Common genetic variation in GNG4 and KCNQ2 was associated with cognitive decline. In human brain tissue data sets, both GNG4 and KCNQ2 show higher expression in hippocampus relative to other brain regions; GNG4 expression decreases with advancing age. Both GNG4 and KCNQ2 show highest expression in fetal astrocytes. CONCLUSION: Genetic variation analyses and gene expression data suggest that GNG4 and KCNQ2 may be associated with cognitive decline in normal aging. Gene-based testing of neurotransmitter pathways may confirm and reveal novel risk genes in future studies of healthy cognitive aging.
BACKGROUND/RATIONALE: Experimental studies support the role of neurotransmitter genes in dementia risk, but human studies utilizing single variants in candidate genes have had limited success. METHODS: We used the gene-based testing program Versatile Gene-based Association Study to assess whether aggregate variation across 6 neurotransmitter pathways influences risk of cognitive decline in 8159 cognitively normal elderly (≥65 years old) adults from 3 community-based cohorts. RESULTS: Common genetic variation in GNG4 and KCNQ2 was associated with cognitive decline. In human brain tissue data sets, both GNG4 and KCNQ2 show higher expression in hippocampus relative to other brain regions; GNG4 expression decreases with advancing age. Both GNG4 and KCNQ2 show highest expression in fetal astrocytes. CONCLUSION: Genetic variation analyses and gene expression data suggest that GNG4 and KCNQ2 may be associated with cognitive decline in normal aging. Gene-based testing of neurotransmitter pathways may confirm and reveal novel risk genes in future studies of healthy cognitive aging.
Authors: Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman Journal: Alcohol Alcohol Date: 2008-05-12 Impact factor: 2.826
Authors: R O'Hara; C M Schröder; R Mahadevan; A F Schatzberg; S Lindley; S Fox; M Weiner; H C Kraemer; A Noda; X Lin; H L Gray; J F Hallmayer Journal: Mol Psychiatry Date: 2007-03-13 Impact factor: 15.992
Authors: Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke Journal: Neuron Date: 2007-09-06 Impact factor: 17.173
Authors: Hyo Jung Kang; Yuka Imamura Kawasawa; Feng Cheng; Ying Zhu; Xuming Xu; Mingfeng Li; André M M Sousa; Mihovil Pletikos; Kyle A Meyer; Goran Sedmak; Tobias Guennel; Yurae Shin; Matthew B Johnson; Zeljka Krsnik; Simone Mayer; Sofia Fertuzinhos; Sheila Umlauf; Steven N Lisgo; Alexander Vortmeyer; Daniel R Weinberger; Shrikant Mane; Thomas M Hyde; Anita Huttner; Mark Reimers; Joel E Kleinman; Nenad Sestan Journal: Nature Date: 2011-10-26 Impact factor: 49.962
Authors: Sharmelee Selvaraji; Motakis Efthymios; Roger Sik Yin Foo; David Y Fann; Mitchell Kim Peng Lai; Christopher Li Hsian Chen; Kah Leong Lim; Thiruma V Arumugam Journal: Theranostics Date: 2022-03-21 Impact factor: 11.600
Authors: Andrea Ciolfi; Erfan Aref-Eshghi; Simone Pizzi; Lucia Pedace; Evelina Miele; Jennifer Kerkhof; Elisabetta Flex; Simone Martinelli; Francesca Clementina Radio; Claudia A L Ruivenkamp; Gijs W E Santen; Emilia Bijlsma; Daniela Barge-Schaapveld; Katrin Ounap; Victoria Mok Siu; R Frank Kooy; Bruno Dallapiccola; Bekim Sadikovic; Marco Tartaglia Journal: Clin Epigenetics Date: 2020-01-07 Impact factor: 6.551